» Articles » PMID: 24049445

Development and Characterization of Dilutable Self-microemulsifying Premicroemulsion Systems (SMEPMS) As Templates for Preparation of Nanosized Particulates

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2013 Sep 20
PMID 24049445
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The utilization of self-microemulsifying premicroemulsion systems (SMEPMS) as templates for preparing poorly water-soluble compounds in the nanosized range represents a promising strategy. Fenofibrate was formulated with n-butyl L-lactate, Tween 80, and a number of cosurfactants (ethanol, 1-propanol, and PEG 600), diluted with the water phase (either water or saccharide solution) and then subjected to a freeze-drying (FD) process to obtain SMEPMS nanosized particulates. Results demonstrated that the particle size after resuspension of these FD SMEPMS nanosized particulates in water was too large, so the addition of saccharide solutions (lactose, mannitol, glucose, sucrose, and trehalose) as the solid carrier to prevent particles from aggregating seemed to be necessary and workable due to steric hindrance and repulsion. However, instability of these resuspended FD nanosized particulates after 30-90 minutes still occurred, and the addition of 0.5% sodium lauryl sulfate in the resuspending medium was able to retard the aggregation and maintain the particle size within the nano-range. Evaluation by scanning electron microscopy and X-ray powder diffraction also confirmed the results. It was concluded that using an SMEPMS formulation with PEG 600 as the cosurfactant, and in the presence of a suitable saccharide as an anticaking agent and FD process were able to produce fenofibrate nanoparticles.

Citing Articles

Synergistic Combination of Irinotecan and Rapamycin Orally Delivered by Nanoemulsion for Enhancing Therapeutic Efficacy of Pancreatic Cancer.

Liu Y, Chen L, Cheng W, Wei P, Hsieh C, Sheu M Pharmaceutics. 2023; 15(2).

PMID: 36839795 PMC: 9963937. DOI: 10.3390/pharmaceutics15020473.


CPT11 with P-glycoprotein/CYP 3A4 dual-function inhibitor by self-nanoemulsifying nanoemulsion combined with gastroretentive technology to enhance the oral bioavailability and therapeutic efficacy against pancreatic adenocarcinomas.

Chen L, Cheng W, Lin S, Hung M, Sheu M, Lin H Drug Deliv. 2021; 28(1):2205-2217.

PMID: 34662257 PMC: 8525948. DOI: 10.1080/10717544.2021.1989087.

References
1.
Stuchlik M, Zak S . Lipid-based vehicle for oral drug delivery. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2002; 145(2):17-26. View

2.
Venkatesh G, Majid M, Mansor S, Nair N, Croft S, Navaratnam V . In vitro and in vivo evaluation of self-microemulsifying drug delivery system of buparvaquone. Drug Dev Ind Pharm. 2010; 36(6):735-45. DOI: 10.3109/03639040903460446. View

3.
Constantinides P . Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 1995; 12(11):1561-72. DOI: 10.1023/a:1016268311867. View

4.
Kim J, Ku Y . Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats. Int J Pharm. 1999; 194(1):81-9. DOI: 10.1016/s0378-5173(99)00367-1. View

5.
Trotta M, Gallarate M, Carlotti M, Morel S . Preparation of griseofulvin nanoparticles from water-dilutable microemulsions. Int J Pharm. 2003; 254(2):235-42. DOI: 10.1016/s0378-5173(03)00029-2. View